Your browser doesn't support javascript.
loading
The emergence and ongoing convergent evolution of the N501Y lineages coincides with a major global shift in the SARS-CoV-2 selective landscape.
Martin, Darren P; Weaver, Steven; Tegally, Houryiah; San, Emmanuel James; Shank, Stephen D; Wilkinson, Eduan; Lucaci, Alexander G; Giandhari, Jennifer; Naidoo, Sureshnee; Pillay, Yeshnee; Singh, Lavanya; Lessells, Richard J; Gupta, Ravindra K; Wertheim, Joel O; Nekturenko, Anton; Murrell, Ben; Harkins, Gordon W; Lemey, Philippe; MacLean, Oscar A; Robertson, David L; de Oliveira, Tulio; Kosakovsky Pond, Sergei L.
Affiliation
  • Martin DP; Institute of Infectious Diseases and Molecular Medicine, Division Of Computational Biology, Department of Integrative Biomedical Sciences, University of Cape Town, South Africa.
  • Weaver S; Institute for Genomics and Evolutionary Medicine, Department of Biology, Temple University, Pennsylvania, USA.
  • Tegally H; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine & Medical Sciences, University of KwaZulu- Natal, Durban, South Africa.
  • San EJ; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine & Medical Sciences, University of KwaZulu- Natal, Durban, South Africa.
  • Shank SD; Institute for Genomics and Evolutionary Medicine, Department of Biology, Temple University, Pennsylvania, USA.
  • Wilkinson E; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine & Medical Sciences, University of KwaZulu- Natal, Durban, South Africa.
  • Lucaci AG; Institute for Genomics and Evolutionary Medicine, Department of Biology, Temple University, Pennsylvania, USA.
  • Giandhari J; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine & Medical Sciences, University of KwaZulu- Natal, Durban, South Africa.
  • Naidoo S; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine & Medical Sciences, University of KwaZulu- Natal, Durban, South Africa.
  • Pillay Y; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine & Medical Sciences, University of KwaZulu- Natal, Durban, South Africa.
  • Singh L; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine & Medical Sciences, University of KwaZulu- Natal, Durban, South Africa.
  • Lessells RJ; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine & Medical Sciences, University of KwaZulu- Natal, Durban, South Africa.
  • Gupta RK; Clinical Microbiology, University of Cambridge, Cambridge, UK.
  • Wertheim JO; Africa Health Research Institute, KwaZulu-Natal, South Africa.
  • Nekturenko A; Department of Medicine, University of California San Diego, La Jolla, CA, USA.
  • Murrell B; Department of Biochemistry and Molecular Biology, The Pennsylvania State University, Pennsylvania, USA.
  • Harkins GW; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Lemey P; South African Medical Research Council Capacity Development Unit, South African National Bioinformatics Institute, University of the Western cape, Bellville, South Africa.
  • MacLean OA; Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.
  • Robertson DL; MRC-University of Glasgow Centre for Virus Research, Scotland, UK.
  • de Oliveira T; MRC-University of Glasgow Centre for Virus Research, Scotland, UK.
  • Kosakovsky Pond SL; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine & Medical Sciences, University of KwaZulu- Natal, Durban, South Africa.
medRxiv ; 2021 Jul 25.
Article in En | MEDLINE | ID: mdl-33688681
ABSTRACT
The emergence and rapid rise in prevalence of three independent SARS-CoV-2 "501Y lineages", B.1.1.7, B.1.351 and P.1, in the last three months of 2020 prompted renewed concerns about the evolutionary capacity of SARS-CoV-2 to adapt to both rising population immunity, and public health interventions such as vaccines and social distancing. Viruses giving rise to the different 501Y lineages have, presumably under intense natural selection following a shift in host environment, independently acquired multiple unique and convergent mutations. As a consequence, all have gained epidemiological and immunological properties that will likely complicate the control of COVID-19. Here, by examining patterns of mutations that arose in SARSCoV-2 genomes during the pandemic we find evidence of a major change in the selective forces acting on various SARS-CoV-2 genes and gene segments (such as S, nsp2 and nsp6), that likely coincided with the emergence of the 501Y lineages. In addition to involving continuing sequence diversification, we find evidence that a significant portion of the ongoing adaptive evolution of the 501Y lineages also involves further convergence between the lineages. Our findings highlight the importance of monitoring how members of these known 501Y lineages, and others still undiscovered, are convergently evolving similar strategies to ensure their persistence in the face of mounting infection and vaccine induced host immune recognition.

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: MedRxiv Year: 2021 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: MedRxiv Year: 2021 Document type: Article Affiliation country: